Paul Donovan
Paul Donovan
agreement continue definitive expect position sign weeks
We continue to expect to be in a position to sign a definitive agreement in the first two weeks of January.
economy european pause perhaps position stronger time
The U.K economy is in a stronger position than many European economies, and perhaps now is the time to pause for a bit,
consumers economy happening jobs less lose losing money spend vicious worried worry
What's happening is that consumers are worried about losing their jobs, and if consumers worry about losing their jobs, they spend less money -- so the economy slows down, so they lose their jobs -- it's a vicious circle.
action bearing believe issue legal proposed threats
We believe this issue has no bearing on our proposed acquisition of Guidant. Unfortunately, threats of legal action are commonplace in our industry.
access changes designed ensure final fullest innovative possible recommend regulation
We will recommend changes designed to ensure that the final regulation preserves the fullest possible beneficiary access to innovative technologies and therapies.
boston brought companies confident family prospects scientific
We have brought a lot of companies into the Boston Scientific family and we have never been more confident or enthusiastic about the prospects for a merger.
agreement continue definitive diligence due forward goal move reaching
We continue to move forward with our due diligence with the goal of reaching a definitive agreement with Guidant.
agreement continue definitive diligence due forward goal move reaching
We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant. I don't think we're going to have anything more to say right now.
agreement believe continue definitive diligence due employees forward goal johnson move offering potential proposal reaching revised strong upside
We continue to believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.
agreement believe continue definitive diligence due employees forward goal johnson move offering potential proposal reaching revised strong upside
We continue to believe our $72 (per share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time. We continue to move forward on our due diligence with the goal of reaching a definitive agreement with Guidant.
believe continue employees johnson offering potential proposal revised strong upside
We continue to believe our $72 (a share) proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.
believe employees johnson offering potential proposal revised strong upside
We believe our $72 proposal is better for Guidant, its shareholders and its employees than Johnson & Johnson's revised offer. We are offering significantly more value, and there is strong upside potential over time.
businesses commodity costs empty lower moment problem production
Unfortunately, I don't think this is an empty threat. The problem for Philips is they are in such commodity businesses at the moment and production costs are much lower in Asia.
beat believe consensus estimates good met street wall
It was a very good quarter. We beat Wall Street consensus estimates for revenue, and we believe we met them for earnings.